Caas Capital Management LP Opti Nose, Inc. Transaction History

Caas Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.47 - $4.75 $721,909 - $988,204	-208,043 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$3.2 - $4.98 $577,782 - $899,173	-180,557 Reduced 46.46%	208,043 $861,000
Q3 2020 Nov 09, 2020	BUY	$3.69 - $7.09 $1.43 Million - $2.76 Million	388,600 New	388,600 $1.52 Million
Q2 2020 Aug 14, 2020	SELL	$3.58 - $7.44 $282,218 - $586,510	-78,832 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.49 - $9.2 $275,123 - $725,254	78,832 New	78,832 $354,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.